Money Concepts Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Money Concepts Capital's AZN Position: Q2 2026 in Review
Money Concepts Capital reduced its AstraZeneca (AZN) stake by 3.9% in Q2 2026, selling an estimated $115K and leaving 15,188 shares worth $2.84M. The position accounts for 0.13% of the portfolio, ranked #150.
Money Concepts Capital first reported a position in AZN in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.06M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Money Concepts Capital held 15,188 shares of AstraZeneca worth $2.84M as of Q2 2026.
- Money Concepts Capital sold 613 AstraZeneca shares in Q2 2026, an estimated $115K.
- AstraZeneca made up 0.13% of Money Concepts Capital's portfolio in Q2 2026, its #150 holding.
- Money Concepts Capital first reported a position in AstraZeneca in Q4 2020 and has held it in 21 quarters since.
- Money Concepts Capital's AstraZeneca position peaked at $3.06M in Q1 2026.
- 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Money Concepts Capital's 13F filing for Q2 2026, filed 4 Aug 2026.